
| Cat. No. | Volume | |
| FBS Pharma Grade | ||
| AUS origin | A11-511 | 100 ml |
| A15-511 | 500 ml | |
| FBS Pharma Grade | ||
| Gamma Irradiated | ||
| AUS origin | A11-512 | 100 ml |
| A15-512 | 500 ml | |
| FBS Pharma Grade | ||
| USA origin | A11-211 | 100 ml |
| A15-211 | 500 ml | |
| FBS Pharma Grade | ||
| Gamma Irradiated | ||
| USA origin | A11-212 | 100 ml |
| A15-212 | 500 ml |
FBS Pharma Grade is a high quality Foetal Bovine Serum which complies with all current directives, regulations and guidelines regulating the manufacture of biopharmaceutical products. These regulations comprise the EMEA guideline 1793/02 of the committee for proprietary medical products (CPMP), EMEA guideline 743/00 of the committee for veterinary medical products (CVMP), the Ph. Eur. (European Pharmacopoeia) 5.4 monograph of Bovine Serum (04/2006:2262) and US Code of Federal Regulation (9CFR). An extensive test panel of mycoplasma, ten different viruses, BVD antibodies and BVD antibody interferences as well as biochemical and cell culture parameters minimize the risks in biopharmaceutical processes.
FBS Pharma Grade is suitable for cell based products which need to be produced and registered in compliance with the EU regulation 2005/567 for Advanced Therapies (AT).
| pH | 6.8 – 8.2 |
| Osmolality | 280 – 365 mOsmol/kg |
| Total Protein | 3.0 – 4.5 g/dl |
| Albumin | value |
| Endotoxin | < 25 EU/ml |
| IgG | < 250 µg/ml |
| Haemoglobin | < 4 mg/ml |
| Sterility | tested |
| Mycoplasma | not detected |
| Virus tested for | Parainfluenza Type 3 (PI-3), Bovine Virus Diarrhoea Virus (BVD-V), Bovine Herpes Virus Type 1 (BHV-1), Blue Tongue Virus (BTV), Bovine Adenovirus (BAV), Bovine Reovirus (BRV), Bovine Parvovirus (BPV), Bovine Respiratory Syncytial Virus (BRSV), Rabies Virus, BVD-1 AB, BVD-2 AB, Rabies AB, BVDV AB Inhibitory, BVDV AB Interferences |
| Shelf Life | 5 years |
| Storage | ≤-15 °C |
For each batch complete documentation can be requested.
* Other origins available on request